It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
The Italian Society for Rheumatology studied 65,000 patients on longterm hydroxychloroquine for RA and Lupus.
Only 20 patients tested positive for COVID-19. No ICU, no deaths.
This is a 90% reduction in infection rate compared to the rest of Italy.
originally posted by: infolurker
It appears this drug does work. Recent studies in the US have been with patients already admitted to the hospital and a little late to halt the viral replication by that time. It appears this must be given early to have the most impact but zero ICU and zero deaths is pretty impressive.
www.iltempo.it/salute/2020/04/28/news/coronavirus-farmaci-efficaci-news-danni-cura-annalisa-chiusolo-artrite-terapia-idrossiclorochina-sars-cov2-13212 27/
www.thegatewaypundit.com...
The Italian Society for Rheumatology studied 65,000 patients on longterm hydroxychloroquine for RA and Lupus.
Only 20 patients tested positive for COVID-19. No ICU, no deaths.
This is a 90% reduction in infection rate compared to the rest of Italy.
I wish Trump had not mentioned it simply because the entire leftest news HAD to prove him wrong by any means necessary which is a disservice to the public.
Of course this drug should not be used because it is generic and cheap. We need an expensive drug that will make the big Pharma companies a lot of money.
originally posted by: puzzled2
a reply to: infolurker
SO we can't pre-take it but can we use it as a "morning after" pill ? Once you have symptoms and are not in the known to have problems group. get the vit D, vit c, hcq, zinc, magnesium boosters
originally posted by: shawmanfromny
a reply to: Doctor Smith
Take Tamiflu within 48 hours of flu symptom onset. You have a choice of capsules or liquid. It’s best to take Tamiflu with food—there is less chance of stomach upset if you take it with a light snack or a meal.
If you have already been exposed to the flu, but you don't have any symptoms, you can take Tamiflu for up to 6 weeks to help prevent you from getting sick.
originally posted by: Doctor Smith
Looks like Trump is right again. And the left just opposes for no reason endangering us all.
originally posted by: Serdgiam
a reply to: Advantage
Seems like Dr. Yadegar from Cedars-Sinai might have some insight into that:
Kinda wish Beck woulda shut up.. But hey, the info & data will hopefully become more readily available.
In between RdRPs inhibitors (seems like we got one for each political side.. HCQ+Zinc/Remdesivir) and Yadegar's approach, we are starting to get a few prongs to tackle things with.
Although several drugs have been proposed as treatment options, there are no data on the effectiveness and safety of post-exposure prophylaxis (PEP) for COVID-19. After a large COVID-19 exposure event in an LTCH in Korea, PEP using hydroxychloroquine (HCQ) was administered to 211 individuals, including 189 patients and 22 careworkers, whose baseline polymerase chain reaction (PCR) tests for COVID-19 were negative. PEP was completed in 184 (97.4%) patients and 21 (95.5%) careworkers without serious adverse events. At the end of 14 days of quarantine, all follow-up PCR tests were negative. Based on our experience, further clinical studies are recommended for COVID-19 PEP.
originally posted by: carewemust
a reply to: infolurker
There's a lot more to be eventually revealed about Hydroxychloroquine combos preventing all manner of illness. That data is buried now, because the drug is cheap. But it won't stay buried much longer, according to anonymous insiders.
Hydroxychloroquine is approved for the treatment of non-cancerous illnesses such as rheumatoid arthritis and systemic lupus erythematous. Researchers in the laboratory have tested tumors from patients with pancreatic cancer and have discovered that they have certain pathways inside the cells that promote growth and survival of the tumor. Hydroxychloroquine may inactivate these pathways and results in the death of pancreatic cancer cells.
Scientific evidence also supports the use of CQ and HCQ in the treatment of cancer. Overall, preclinical studies support CQ and HCQ use in anti-cancer therapy, especially in combination with conventional anti-cancer treatments since they are able to sensitise tumour cells to a variety of drugs, potentiating the therapeutic activity.
Thus far, clinical results are mostly in favour of the repurposing of CQ. However, over 30 clinical studies are still evaluating the activity of both CQ and HCQ in different cancer types and in combination with various standard treatments.
Interestingly, CQ and HCQ exert effects both on cancer cells and on the tumour microenvironment. In addition to inhibition of the autophagic flux, which is the most studied anti-cancer effect of CQ and HCQ, these drugs affect the Toll-like receptor 9, p53 and CXCR4-CXCL12 pathway in cancer cells.